In turn, the accumulation of 2-HG in cells competitively inhibits α-ketoglutarate-dependent processes as the function of the TET2 enzyme, whose mutation afflicts about 20% of AML [25,48,49,50]. This evidence concerns the gene TET2 and acute myeloid leukemia.